PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response.
Animals
BRCA1 Protein
/ genetics
BRCA2 Protein
/ genetics
Cell Line, Tumor
Checkpoint Kinase 1
/ metabolism
Checkpoint Kinase 2
/ metabolism
Fanconi Anemia Complementation Group N Protein
/ genetics
G2 Phase Cell Cycle Checkpoints
HCT116 Cells
HEK293 Cells
Humans
Mice
Phosphorylation
Recombinational DNA Repair
Journal
Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
10
02
2018
accepted:
21
09
2018
revised:
13
08
2018
pubmed:
20
10
2018
medline:
15
5
2019
entrez:
20
10
2018
Statut:
ppublish
Résumé
The G2/M checkpoint inhibits mitotic entry upon DNA damage, thereby preventing segregation of broken chromosomes and preserving genome stability. The tumor suppressor proteins BRCA1, PALB2 and BRCA2 constitute a BRCA1-PALB2-BRCA2 axis that is essential for homologous recombination (HR)-based DNA doublestrand break repair. Besides HR, BRCA1 has been implicated in both the initial activation and the maintenance of the G2/M checkpoint, while BRCA2 and PALB2 have been shown to be critical for its maintenance. Here we show that all three proteins can play a significant role in both checkpoint activation and checkpoint maintenance, depending on cell type and context, and that PALB2 links BRCA1 and BRCA2 in the checkpoint response. The BRCA1-PALB2 interaction can be important for checkpoint activation, whereas the PALB2-BRCA2 complex formation appears to be more critical for checkpoint maintenance. Interestingly, the function of PALB2 in checkpoint response appears to be independent of CHK1 and CHK2 phosphorylation. Following ionizing radiation, cells with disengaged BRCA1-PALB2 interaction show greatly increased chromosomal abnormalities due apparently to combined defects in HR and checkpoint control. These findings provide new insights into DNA damage checkpoint control and further underscore the critical importance of the proper cooperation of the BRCA and PALB2 proteins in genome maintenance.
Identifiants
pubmed: 30337689
doi: 10.1038/s41388-018-0535-2
pii: 10.1038/s41388-018-0535-2
pmc: PMC6408219
mid: NIHMS1507950
doi:
Substances chimiques
BRCA1 Protein
0
BRCA1 protein, human
0
BRCA2 Protein
0
BRCA2 protein, human
0
Fanconi Anemia Complementation Group N Protein
0
PALB2 protein, human
0
Checkpoint Kinase 2
EC 2.7.1.11
CHEK1 protein, human
EC 2.7.11.1
CHEK2 protein, human
EC 2.7.11.1
Checkpoint Kinase 1
EC 2.7.11.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1585-1596Subventions
Organisme : NCI NIH HHS
ID : R01 CA138804
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
ID : R01CA188096
Pays : International
Organisme : NCI NIH HHS
ID : R01 CA169182
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
ID : R01CA169182
Pays : International
Organisme : NCI NIH HHS
ID : R01 CA190858
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
ID : R01CA190858
Pays : International
Organisme : U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
ID : R01CA138804
Pays : International
Organisme : NCI NIH HHS
ID : R01 CA188096
Pays : United States
Références
Nat Genet. 2007 Feb;39(2):159-61
pubmed: 17200672
Nat Genet. 2001 Dec;29(4):418-25
pubmed: 11694875
Mol Cell Biol. 2012 Apr;32(8):1506-17
pubmed: 22331464
Mol Cell Biol. 2001 May;21(10):3445-50
pubmed: 11313470
Curr Opin Cell Biol. 2007 Apr;19(2):238-45
pubmed: 17303408
Curr Biol. 2009 Mar 24;19(6):524-9
pubmed: 19268590
J Cell Biol. 2014 Aug 18;206(4):493-507
pubmed: 25113031
Cell. 2013 Jan 31;152(3):620-32
pubmed: 23352430
J Biol Chem. 2014 Aug 29;289(35):24617-29
pubmed: 25016020
Mol Cell. 2010 Oct 22;40(2):179-204
pubmed: 20965415
Nat Rev Cancer. 2011 Dec 23;12(1):68-78
pubmed: 22193408
Mol Cell. 2006 Jun 23;22(6):719-29
pubmed: 16793542
Science. 2014 Mar 28;343(6178):1466-70
pubmed: 24675953
Nat Rev Mol Cell Biol. 2010 Mar;11(3):196-207
pubmed: 20177395
Hered Cancer Clin Pract. 2015 Aug 01;13(1):16
pubmed: 26236408
Science. 2003 Oct 24;302(5645):639-42
pubmed: 14576433
Nat Genet. 2002 Mar;30(3):285-9
pubmed: 11836499
Biomed Res Int. 2013;2013:747318
pubmed: 23586058
Nat Commun. 2015 Dec 22;6:10086
pubmed: 26689913
Oncogene. 2013 Oct 17;32(42):5005-16
pubmed: 23246971
Science. 2014 Mar 28;343(6178):1470-5
pubmed: 24675954
Oncogene. 2004 Jan 29;23(4):865-72
pubmed: 14647413
Mol Cell. 1999 Mar;3(3):389-95
pubmed: 10198641
Cancer Discov. 2013 Aug;3(8):894-907
pubmed: 23650262
Genes Dev. 2011 Mar 1;25(5):409-33
pubmed: 21363960
Clin Cancer Res. 2010 Jan 1;16(1):99-108
pubmed: 20008842
EMBO Rep. 2011 Jul 01;12(7):705-12
pubmed: 21637299
Science. 1998 Nov 20;282(5393):1497-501
pubmed: 9822382
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18032-7
pubmed: 22006311
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7155-60
pubmed: 19369211
Oncogene. 2001 Apr 5;20(15):1803-15
pubmed: 11313928
Cancer Res. 2010 Oct 1;70(19):7353-9
pubmed: 20858716
Mol Cancer Res. 2009 Jul;7(7):1110-8
pubmed: 19584259
Nat Rev Cancer. 2007 Nov;7(11):861-9
pubmed: 17943134
Oncogene. 2017 Jul 20;36(29):4161-4170
pubmed: 28319063
J Biol Chem. 2003 Sep 19;278(38):35979-87
pubmed: 12815053
Cell Rep. 2014 Oct 23;9(2):451-9
pubmed: 25310973
EMBO Rep. 2009 Sep;10(9):990-6
pubmed: 19609323
Nature. 2015 Dec 17;528(7582):422-6
pubmed: 26649820
Cancer Res. 1998 Feb 15;58(4):767-78
pubmed: 9485033
Science. 2011 Jun 10;332(6035):1313-7
pubmed: 21659603
Cytometry. 1998 Jun 1;32(2):71-7
pubmed: 9627219
Mol Cell Biol. 2004 Nov;24(21):9478-86
pubmed: 15485915
Cell. 2010 Apr 16;141(2):243-54
pubmed: 20362325